Marcello D. Bronstein

11.1k total citations · 4 hit papers
158 papers, 6.2k citations indexed

About

Marcello D. Bronstein is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Marcello D. Bronstein has authored 158 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Endocrinology, Diabetes and Metabolism, 62 papers in Surgery and 27 papers in Epidemiology. Recurrent topics in Marcello D. Bronstein's work include Pituitary Gland Disorders and Treatments (138 papers), Growth Hormone and Insulin-like Growth Factors (110 papers) and Adrenal and Paraganglionic Tumors (61 papers). Marcello D. Bronstein is often cited by papers focused on Pituitary Gland Disorders and Treatments (138 papers), Growth Hormone and Insulin-like Growth Factors (110 papers) and Adrenal and Paraganglionic Tumors (61 papers). Marcello D. Bronstein collaborates with scholars based in Brazil, United States and Italy. Marcello D. Bronstein's co-authors include Шломо Мелмед, Felipe F. Casanueva, Andréa Glezer, Philippe Chanson, Anne Klibanski, Raquel S. Jallad, Andrea Giustina, Mônica R. Gadelha, Nina Rosa de Castro Musolino and John Wass and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Molecular Cancer.

In The Last Decade

Marcello D. Bronstein

152 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Consensus on Criteria for Cure of Acromegaly

2010 597 citations Andrea Giustina, Philippe Chanson et al. The Journal of Clinical Endocrinology & Metabolism profile →
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas

2006 533 citations Felipe F. Casanueva, Mark E. Molitch et al. Clinical Endocrinology profile →
A Consensus Statement on acromegaly therapeutic outcomes

2018 389 citations Шломо Мелмед, Marcello D. Bronstein et al. profile →
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study

2014 302 citations Annamaria Colao, Marcello D. Bronstein et al. The Journal of Clinical Endocrinology & Metabolism profile →

Peers

Countries citing papers authored by Marcello D. Bronstein

Since Specialization

Citations

This map shows the geographic impact of Marcello D. Bronstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcello D. Bronstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcello D. Bronstein more than expected).

Fields of papers citing papers by Marcello D. Bronstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcello D. Bronstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcello D. Bronstein. The network helps show where Marcello D. Bronstein may publish in the future.

Co-authorship network of co-authors of Marcello D. Bronstein

This figure shows the co-authorship network connecting the top 25 collaborators of Marcello D. Bronstein. A scholar is included among the top collaborators of Marcello D. Bronstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcello D. Bronstein. Marcello D. Bronstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Consensus Statement on acromegaly therapeutic outcomes 2025 ·UNC Libraries ·John Wass, Anne Klibanski, Шломо Мелмед, Philippe Chanson, David R. Clemmons, Christian J. Strasburger, Marcello D. Bronstein, (unknown), Andrea Giustina, Felipe F. Casanueva	0
2	Cabergoline should be attempted in progressing non-functioning pituitary macroadenoma 2021 ·European Journal of Endocrinology ·Yona Greenman, Marcello D. Bronstein	17
3	The effects of cabergoline in the presurgical and recurrence periods of Cushing's disease patients 2021 ·Minerva Endocrinology ·(unknown), (unknown), (unknown), Valter Ângelo Sperling Cescato, (unknown), Maria Candida Barisson Villares Fragoso, Marcello D. Bronstein, (unknown)	1
4	Risk factors and management of pasireotide-associated hyperglycemia in acromegaly 2020 ·Endocrine Connections ·Mônica R. Gadelha, Feng Gu, Marcello D. Bronstein, Thierry Brue, Maria Fleseriu, Ilan Shimon, A. J. van der Lely, Shoba Ravichandran, Albert Kandra, Alberto M Pedroncelli, (unknown)	40
5	Filamin A and DRD2 expression in corticotrophinomas 2019 ·Pituitary ·(unknown), Ericka Barbosa Trarbach, (unknown), (unknown), Venâncio Avancini Ferreira Alves, Maria Candida Barisson Villares Fragoso, Márcio Carlos Machado, Ellison Fernando Cardoso, Marcello D. Bronstein, Andréa Glezer	6
6	Outcome of pregnancies in a large cohort of women with acromegaly 2018 ·Clinical Endocrinology ·Raquel S. Jallad, Ilan Shimon, Merav Fraenkel, (unknown), Amit Akirov, (unknown), Marcello D. Bronstein	17
7	Apoplexy in nonfunctioning pituitary adenomas 2018 ·Pituitary ·Luiz Eduardo Wildemberg, Andréa Glezer, Marcello D. Bronstein, Mônica R. Gadelha	42
8	Management of pituitary tumors during pregnancy and lactation 2018 ·Current Opinion in Endocrine and Metabolic Research ·Andréa Glezer, Raquel S. Jallad, Márcio Carlos Machado, Maria Candida Barisson Villares Fragoso, Marcello D. Bronstein	2
9	Sagit©: A Novel Clinician-Reported Outcome for Managing Acromegaly in Clinical Practice 2014 ·Value in Health ·Andrea Giustina, John S. Bevan, Marcello D. Bronstein, Felipe F. Casanueva, Philippe Chanson, Stephan Petersenn, (unknown), Christine Massien, (unknown), Isabelle Guillemin, Benoît Arnould, Шломо Мелмед	3
10	Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study 2014 ·Pituitary ·Michael C. Sheppard, Marcello D. Bronstein, Pamela U. Freda, Omar Serri, Laura De Marinis, Luciana Ansaneli Naves, Liudmila Rozhinskaya, Karina Hermosillo Reséndiz, Matthieu Ruffin, (unknown), Annamaria Colao	67
11	Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial 2014 ·The Lancet Diabetes & Endocrinology ·Mônica R. Gadelha, Marcello D. Bronstein, Thierry Brue, Mihail Coculescu, Maria Fleseriu, Mirtha Guitelman, Vyacheslav Pronin, Gérald Raverot, Ilan Shimon, (unknown), (unknown), Mounir Aout, Alberto M Pedroncelli, Annamaria Colao	284
12	Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study 2012 ·15th International & 14th European Congress of Endocrinology ·Annamaria Colao, Marcello D. Bronstein, Pamela U. Freda, Feng Gu, (unknown), Mônica R. Gadelha, Maria Fleseriu, (unknown), Matthieu Ruffin, (unknown), Mary N. Sheppard	12
13	Pasireotide LAR vs octreotide LAR in patients with acromegaly: double-blind, crossover, extension period to a randomized, double-blind, multicenter, phase III study 2012 ·15th International & 14th European Congress of Endocrinology ·Maria Fleseriu, M C Sheppard, Marcello D. Bronstein, Pamela U. Freda, Feng Gu, Chiung‐Chyi Shen, Mônica R. Gadelha, (unknown), Matthieu Ruffin, (unknown), Annamaria Colao	3
14	Hypopituitarism due to Hydrocephalus: Case Report and Review of the Literature 2011 ·Pediatric Neurosurgery ·Fernando Campos Gomes Pinto, (unknown), (unknown), (unknown), Marcello D. Bronstein, Manoel Jacobsen Teixeira	4
15	iASPP: A Novel Protein Involved in Pituitary Tumorigenesis? 2010 ·Frontiers of hormone research ·Emília M. Pinto, Nina Rosa de Castro Musolino, Valter Ângelo Sperling Cescato, Iberê Cauduro Soares, Alda Wakamatsu, Evandro de Oliveira, Luiz Roberto Salgado, Marcello D. Bronstein	4
16	Current management practices for acromegaly: an international survey 2010 ·Pituitary ·Andrea Giustina, Marcello D. Bronstein, Felipe F. Casanueva, Philippe Chanson, Ezio Ghigo, Ken K. Y. Ho, Anne Klibanski, Steven W. J. Lamberts, Peter Trainer, Шломо Мелмед	77
17	Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas breakdown → 2006 ·Clinical Endocrinology ·Felipe F. Casanueva, Mark E. Molitch, Janet Schlechte, Roger Abs, Vivien Bonert, Marcello D. Bronstein, Thierry Brue, Paolo Cappabianca, Annamaria Colao, Rudolf Fahlbusch, Hugo Fideleff, Moshe Hadani, Paul A. Kelly, David L. Kleinberg, Edward R. Laws, J Marek, M. F. Scanlon, L. G. Sobrinho, John Wass, Andrea Giustina	533
18	Impacto do alcoolismo em mulheres: repercussoes clinicas 2000 ·Archives of Clinical Psychiatry (São Paulo) ·(unknown), Nilson Roberto de Melo, Marcello D. Bronstein, Monica L. Zilberman	2
19	Pituitary Tumor Transforming Gene (PTTG) Expression in Pituitary Adenomas 1999 ·The Journal of Clinical Endocrinology & Metabolism ·Xun Zhang, Gregory A. Horwitz, Anthony P. Heaney, Masahiro Nakashima, Toni R. Prezant, Marcello D. Bronstein, Шломо Мелмед	323
20	Exercício físico e obesidade 1996 ·Marcello D. Bronstein	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact